Smallpox, a severe infectious disease caused by the smallpox virus, causes a death rate as high as 30% within 15–20 days after infection. Therefore, development of an anti-smallpox product as a strategic reserve is urgently ...
Feb 13, 2023
0
19
We've all heard of the psychotherapy couch, and the dynamic between a client and their human therapist. But perhaps less well known is the increasingly popular pet therapy. And no, that's not therapy for your pet—it's the ...
Apr 11, 2022
0
11
A new study by researchers at Children's Hospital of Philadelphia (CHOP) shows that linking a tumor-killing prodrug to a macromolecular carrier of the Poloxamer family improves retention of the drug in treatment-resistant ...
Mar 14, 2022
0
276
A study conducted by a consortium of Brazilian researchers has demonstrated that a hyperimmune serum consisting of purified antibody fragments produced in horses may be an efficient approach to combat COVID-19. Tests conducted ...
Oct 26, 2021
0
38
Following media reports of children with epilepsies reportedly deriving benefits from medical marijuana (or cannabis-based medicinal products) accessed abroad, the UK government allowed clinicians to prescribe these products. ...
Sep 9, 2021
0
16
Researchers at University of California San Diego School of Medicine and Rady Children's Institute for Genomic Medicine have produced a stem cell model that demonstrates a potential route of entry of SARS-CoV-2, the virus ...
Jul 16, 2021
2
252
A light-activated drug that can enter and kill cancer and bacterial cells without harming nearby healthy cells has been tested successfully in zebrafish and cells.
Jun 1, 2021
1
146
A new technology developed by UZH researchers enables the body to produce therapeutic agents on demand at the exact location where they are needed. The innovation could reduce the side effects of cancer therapy and may hold ...
May 17, 2021
1
934
As Belgium's latest wave of coronavirus infections once more fills intensive care beds in hard-pressed hospitals, the average age of victims is dropping as the pandemic moves through the middle-aged.
Apr 6, 2021
0
3
Evidence suggesting an initial half dose of the vaccine being developed by drugs firm AstraZeneca and the University of Oxford is more effective than a full dose is counterintuitive, and even took the researchers by surprise.
Nov 23, 2020
0
9
